These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 5901526)

  • 1. Hyperbaric oxygen, whole-body X irradiation, and cyclophosphamide combination therapy in mouse leukemia L1210.
    Lottsfeldt FI; Schwartz S; Krivit W
    J Natl Cancer Inst; 1966 Jan; 36(1):37-43. PubMed ID: 5901526
    [No Abstract]   [Full Text] [Related]  

  • 2. Biophysical investigations on L1210 mouse leukemia cells treated with activated cyclophosphamide metabolites: determination of selective properties of DNA-interstrand and DNA-protein cross-linking mechanisms (alkaline elution and 31P-NMR-spectroscopy) and some aspects of the combination drug and radiotherapy.
    Ulmer W
    Strahlenther Onkol; 1990 Feb; 166(2):157-63. PubMed ID: 2315845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A biochemical and pharmacological study of therapeutic synergism with 5-fluorouracil plus cyclophosphamide in murine L1210 leukemia.
    Fernandes DJ; Klubes P
    Cancer Res; 1979 Apr; 39(4):1396-404. PubMed ID: 421224
    [No Abstract]   [Full Text] [Related]  

  • 4. Combination of dihydroxyanthraquinone and radiation on L1210 murine leukemia.
    Kimler BF; Hacker MP
    Cancer Clin Trials; 1981; 4(2):173-6. PubMed ID: 7249253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiosensitivity of drug-resistant L1210 leukemia.
    Johnson RE
    Cancer Res; 1967 Feb; 27(2):251-4. PubMed ID: 6018559
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential cytotoxicity and DNA cross-linking produced by polymeric and monomeric activated analogues of cyclophosphamide in mouse L1210 leukemia cells.
    Ramonas LM; Erickson LC; Klesse W; Kohn KW; Zaharko DS
    Mol Pharmacol; 1981 Mar; 19(2):331-6. PubMed ID: 7231393
    [No Abstract]   [Full Text] [Related]  

  • 7. Circadian bioperiodic response of mice bearing advanced L1210 leukemia to combination therapy with adriamycin and cyclophosphamide.
    Scheving LE; Burns ER; Pauly JE; Halberg F
    Cancer Res; 1980 May; 40(5):1511-5. PubMed ID: 7370988
    [No Abstract]   [Full Text] [Related]  

  • 8. Potentiation of the activity of cisplatin and cyclophosphamide by trimidox, a novel ribonucleotide reductase inhibitor, in leukemia-bearing mice.
    Novotny L; Rauko P; Liska J; Elford HL; Szekeres T
    Cancer Lett; 2006 Feb; 233(1):178-84. PubMed ID: 15885888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic action of 2-chlorodeoxyadenosine and cyclophosphamide on murine leukemias L1210 and P388.
    Góra-Tybor J; Robak T
    Acta Haematol Pol; 1993; 24(2):177-82. PubMed ID: 8103959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of benzyl penicillin on cytotoxicity and level of metabolic activity of cyclophosphamide in mice].
    Pakulska W; Graczyk J
    Acta Pol Pharm; 1993; 50(2-3):159-63. PubMed ID: 8030423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experiments in the immunization of hybrid F1 mice against leukemia L1210].
    Brambilla G; Cavanna M; Parodi S; Baldini L
    Arch Ital Patol Clin Tumori; 1968; 11(3):253-61. PubMed ID: 5737806
    [No Abstract]   [Full Text] [Related]  

  • 12. Combined therapy of L1210 leukemia with cyclophosphamide and lycurim.
    Stoychkov JN; Milushev AS; Todorov DK
    Neoplasma; 1980; 27(1):33-6. PubMed ID: 6892839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of antitumor effect of cyclophosphamide by thaliblastine in Lewis lung carcinoma and L1210 leukemia in mice.
    Stoychkov JN; Miloushev AS
    Biomedicine; 1980 Apr; 33(2):42-4. PubMed ID: 6447522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Synergistic effect of nucleoside and cyclophosphamide combination in murine L 1210 leukemia].
    Drings P; Osswald H
    Verh Dtsch Ges Inn Med; 1975; 81():1109-11. PubMed ID: 1229409
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of benzylpenicillin and doxycycline on toxicity and antineoplastic action of cyclophosphamide and methotrexate in mice].
    Pakulska W
    Acta Pol Pharm; 1992; 49(1-2):35-40. PubMed ID: 8769079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current views on drug therapy of tumors].
    Vermel' EM
    Vopr Onkol; 1970; 16(11):108-16. PubMed ID: 4929044
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of 2-chloro-2'-deoxyadenosine alone and in combination with cyclophosphamide or methotrexate on murine leukemia L1210.
    Góra-Tybor J; Robak T; Warzocha K; Grieb P
    Arch Immunol Ther Exp (Warsz); 1994; 42(1):39-42. PubMed ID: 7503633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian optimization of the treatment of L1210 leukemia with 1-beta-D-arabinofuranosylcytosine, cyclophosphamide, vincristine and methylprednisolone.
    Burns ER; Scheving LE
    Chronobiologia; 1980; 7(1):41-51. PubMed ID: 7438892
    [No Abstract]   [Full Text] [Related]  

  • 19. Hematoporphyrin derivative rescue from toxicity caused by chemotherapy or radiation in a murine leukemia model (L1210).
    Canti G; Franco P; Marelli O; Ricci L; Nicolin A
    Cancer Res; 1984 Apr; 44(4):1551-6. PubMed ID: 6231100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single versus combination chemotherapy of L1210 leukemia.
    Koza I; Balázová E; Ujházy V
    Neoplasma; 1980; 27(6):691-6. PubMed ID: 7254424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.